Pickering; Dacia A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Pickering; Dacia A..The latest application filed is for "fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function".

Company Profile

0.6.10

Pickering; Dacia A. - Lawrenceville NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function Grant 7,655,689 - Salvati , et al. February 2, 2	2010-02-02
Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function Grant 7,655,688 - Salvati , et al. February 2, 2	2010-02-02
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function Grant 7,517,904 - Salvati , et al. April 14, 2	2009-04-14
Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function Grant 7,291,637 - Salvati , et al. November 6, 2	2007-11-06
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function Grant 7,141,578 - Salvati , et al. November 28, 2	2006-11-28
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function App 20060264459 - Salvati; Mark E. ; et al.	2006-11-23
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function App 20060223832 - Salvati; Mark E. ; et al.	2006-10-05
Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function Grant 7,087,636 - Salvati , et al. August 8, 2	2006-08-08
Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function App 20060111424 - Salvati; Mark E. ; et al.	2006-05-25
Fused Heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function App 20050272799 - Salvati, Mark E. ; et al.	2005-12-08
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function App 20050192253 - Salvati, Mark E. ; et al.	2005-09-01
Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function App 20050187273 - Salvati, Mark E. ; et al.	2005-08-25
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function App 20040176324 - Salvati, Mark E. ; et al.	2004-09-09
Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function App 20040087548 - Salvati, Mark E. ; et al.	2004-05-06
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function App 20040077605 - Salvati, Mark E. ; et al.	2004-04-22
Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function App 20030181728 - Salvati, Mark E. ; et al.	2003-09-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.